ITEM METADATA RECORD
Title: Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study
Authors: Russell-Jones, David × Cuddihy, Robert M Hanefeld, Markolf Kumar, Ajay González, Jose G Chan, Melanie Wolka, Anne M Boardman, Marilyn K DURATION-4 Study Group #
Contributors: Mathieu, Chantal
Issue Date: Feb-2012
Publisher: American Diabetes Association
Series Title: Diabetes Care vol:35 issue:2 pages:252-258
Abstract: To test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (MET), pioglitazone (PIO), and sitagliptin (SITA) over 26 weeks, in suboptimally treated (diet and exercise) drug-naive patients with type 2 diabetes.
Publication status: published
KU Leuven publication type: IT
Appears in Collections: Clinical and Experimental Endocrinology
× corresponding author
# (joint) last author
Files in This Item:
There are no files associated with this item.
Request a copy
All items in Lirias are protected by copyright, with all rights reserved.
Web of science